Free Trial

ACADIA Pharmaceuticals (ACAD) SEC Filings & 10K Form

$15.10
+0.10 (+0.67%)
(As of 05/31/2024 ET)

Recent ACADIA Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Brege Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
SOLAND DANIEL B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
HARRIGAN EDMUND (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Daly James M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
GAROFALO ELIZABETH A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Ndu Adora (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:23 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
3:21 PM
ACADIA Pharmaceuticals (Filer)
Form DEF 14A
04/15/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Thompson Elizabeth H.Z. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
6:58 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:02 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
6:57 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:07 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:10 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:13 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:08 AM
ACADIA Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
02/09/2024
7:35 AM
ACADIA Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/08/2024
4:05 PM
ACADIA Pharmaceuticals (Issuer)
Rhodes Jennifer J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/08/2024
4:09 PM
ACADIA Pharmaceuticals (Issuer)
Rhodes Jennifer J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
8:55 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
KIM AUSTIN D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
6:37 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
11:46 AM
ACADIA Pharmaceuticals (Subject)
Kihara James (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/28/2023
4:32 PM
ACADIA Pharmaceuticals (Issuer)
GAROFALO ELIZABETH A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
4:11 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:21 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
4:30 PM
ACADIA Pharmaceuticals (Issuer)
Ndu Adora (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
9:00 PM
ACADIA Pharmaceuticals (Issuer)
KIM AUSTIN D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The Only Energy Play You Should Be Looking At (Ad)

Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.

Click here to get all the information about it.
10/06/2023
8:59 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
5:31 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
12:06 PM
ACADIA Pharmaceuticals (Subject)
Kihara James (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2023
6:31 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2023
10:15 AM
ACADIA Pharmaceuticals (Subject)
Schneyer Mark C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/18/2023
5:00 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:01 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2023
10:33 AM
ACADIA Pharmaceuticals (Subject)
DAVIS STEPHEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/13/2023
7:27 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/13/2023
9:42 AM
ACADIA Pharmaceuticals (Subject)
DAVIS STEPHEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/16/2023
3:38 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
10:36 AM
ACADIA Pharmaceuticals (Subject)
Kihara James (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2023
4:14 PM
ACADIA Pharmaceuticals (Issuer)
Brege Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
7:48 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
1:34 PM
ACADIA Pharmaceuticals (Subject)
Brege Laura (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2023
8:43 PM
ACADIA Pharmaceuticals (Issuer)
Ndu Adora (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
8:46 PM
ACADIA Pharmaceuticals (Issuer)
SOLAND DANIEL B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
8:34 PM
ACADIA Pharmaceuticals (Issuer)
GAROFALO ELIZABETH A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
8:38 PM
ACADIA Pharmaceuticals (Issuer)
Daly James M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
8:39 PM
ACADIA Pharmaceuticals (Issuer)
HARRIGAN EDMUND (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
8:42 PM
ACADIA Pharmaceuticals (Issuer)
Brege Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ACAD) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners